UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported):
(Exact Name of Registrant as Specified in Its Charter)
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| |
||
| (Address of Principal Executive Offices) | (Zip Code) |
(Registrant’s Telephone Number, including Area Code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading |
Name of each exchange | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07 Submission of Matters to a Vote of Security Holders
Acadia Healthcare Company, Inc. (the “Company”) held its annual meeting of stockholders on May 6, 2026 (the “Annual Meeting”). The proposals considered at the Annual Meeting were voted on as follows:
1. The individuals listed below were elected to serve as Class III directors until the Company’s annual meeting of stockholders in 2029 or until their successors have been elected and take office. The voting results were as follows:
| For | Against | Abstain | Broker Non-Votes | |||||||||||||
| Daniel J. Cancelmi |
80,276,613 | 608,441 | 50,781 | 5,002,484 | ||||||||||||
| Michael J. Fucci |
73,587,992 | 7,296,976 | 50,867 | 5,002,484 | ||||||||||||
| Patrice A. Harris, M.D., M.A. |
80,535,426 | 350,255 | 50,154 | 5,002,484 | ||||||||||||
2. The Company’s stockholders approved a second amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan, by the following vote:
| For |
Against |
Abstain |
Broker Non-Votes | |||
| 80,102,444 | 779,641 | 53,750 | 5,002,484 |
3. The Company’s stockholders approved, on a non-binding advisory basis, the compensation of the Company’s Named Executive Officers (as defined in the Company’s definitive proxy statement filed with the SEC on March 25, 2026), by the following vote:
| For |
Against |
Abstain |
Broker Non-Votes | |||
| 60,889,503 | 19,942,924 | 103,408 | 5,002,484 |
4. The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, by the following vote:
| For |
Against |
Abstain | ||
| 83,941,435 | 1,947,371 | 49,513 |
Description of Business
Unless the context otherwise requires, all references herein to “Acadia,” “the Company,” “we,” “us” or “our” mean Acadia Healthcare Company, Inc. and its consolidated subsidiaries. Acadia Healthcare Company, Inc. is a holding company whose direct and indirect subsidiaries own and operate acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers, residential treatment centers and facilities providing outpatient behavioral healthcare services to serve the behavioral healthcare and recovery needs of communities throughout the U.S. and Puerto Rico.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
The following exhibits are filed herewith:
| Exhibit No. |
Description | |
| 10.1 | Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan, as amended (a) | |
| 10.2 | Second Amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan (b) | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). | |
| (a) | Incorporated by reference to Appendix B to the Company’s Definitive Proxy Statement filed with the SEC on March 25, 2026 (File No. 001-35331). |
| (b) | Incorporated by reference to Appendix A to the Company’s Definitive Proxy Statement filed with the SEC on March 25, 2026 (File No. 001-35331). |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: May 6, 2026 | ACADIA HEALTHCARE COMPANY, INC. | |||||
| By: | /s/ Brian P. Farley | |||||
| Brian P. Farley | ||||||
| Executive Vice President, Chief Legal and Administrative Officer, and Secretary | ||||||